The effectiveness and value of bempedoic acid and inclisiran for heterozygous familial hypercholesterolemia and secondary prevention of ASCVD: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council

Detalles Bibliográficos
Autores principales: Agboola, Foluso, Lin, Grace A, Kazi, Dhruv S, McKenna, Avery, Pearson, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Perspectives on Value
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391137/
https://www.ncbi.nlm.nih.gov/pubmed/34185561
http://dx.doi.org/10.18553/jmcp.2021.27.7.961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391137/
https://www.ncbi.nlm.nih.gov/pubmed/34185561
http://dx.doi.org/10.18553/jmcp.2021.27.7.961

Ejemplares similares